Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Boeing
BA
|
+$936M |
| 2 |
Amazon
AMZN
|
+$702M |
| 3 |
UnitedHealth
UNH
|
+$685M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$674M |
| 5 |
Bank of America
BAC
|
+$633M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$536M |
| 3 |
Tesla
TSLA
|
+$509M |
| 4 |
Citigroup
C
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$434M |
Sector Composition
| 1 | Healthcare | 16.72% |
| 2 | Technology | 15.86% |
| 3 | Financials | 11.72% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLRN
1126
DELISTED
ACELYRIN
SLRN
| $13.2M | ﹤0.01% |
4,211,916
-2,311,390
| -35% | -$7.26M |
|
1127
KE Holdings
BEKE
$23.7B
| $13.2M | ﹤0.01% |
715,807
-296,311
| -29% | -$5.46M |
|
1128
Vanguard Growth ETF
VUG
$190B
| $13.2M | ﹤0.01% |
32,044
+971
| +3% | +$399K |
|
1129
Tourmaline Bio
TRML
$1.22B
| $13.1M | ﹤0.01% |
648,118
+209,126
| +48% | +$4.24M |
|
1130
General Dynamics
GD
$87.7B
| $13.1M | ﹤0.01% |
49,769
-22,164
| -31% | -$5.84M |
|
|
SOHU
1131
Sohu.com
SOHU
$480M
| $13.1M | ﹤0.01% |
991,164
-6,431
| -0.6% | -$84.8K |
|
1132
Blackrock
BLK
$174B
| $13.1M | ﹤0.01% |
12,738
-207,366
| -94% | -$213M |
|
1133
Invesco National AMT-Free Municipal Bond ETF
PZA
$3.08B
| $13.1M | ﹤0.01% |
552,989
+525,851
| +1,938% | +$12.4M |
|
1134
Polaris
PII
$3.22B
| $13M | ﹤0.01% |
226,159
+81,416
| +56% | +$4.69M |
|
1135
The RealReal
REAL
$1.09B
| $13M | ﹤0.01% |
1,190,729
+767,056
| +181% | +$8.38M |
|
1136
AeroVironment
AVAV
$12.1B
| $13M | ﹤0.01% |
84,221
+59,225
| +237% | +$9.11M |
|
1137
Vital Farms
VITL
$2.17B
| $12.9M | ﹤0.01% |
342,731
-709,439
| -67% | -$26.7M |
|
1138
Ralph Lauren
RL
$19.1B
| $12.9M | ﹤0.01% |
55,909
-119,755
| -68% | -$27.7M |
|
1139
JPMorgan Ultra-Short Income ETF
JPST
$33.5B
| $12.9M | ﹤0.01% |
256,331
+206,748
| +417% | +$10.4M |
|
1140
First Trust Dorsey Wright International Focus 5 ETF
IFV
$174M
| $12.9M | ﹤0.01% |
+671,681
| New | +$12.9M |
|
1141
Xenon Pharmaceuticals
XENE
$2.79B
| $12.8M | ﹤0.01% |
327,303
-395,201
| -55% | -$15.5M |
|
1142
CareTrust REIT
CTRE
$7.62B
| $12.8M | ﹤0.01% |
473,259
+464,611
| +5,372% | +$12.6M |
|
1143
iShares ESG Aware MSCI EM ETF
ESGE
$5.34B
| $12.8M | ﹤0.01% |
382,882
+353,083
| +1,185% | +$11.8M |
|
1144
Acrivon Therapeutics
ACRV
$47.8M
| $12.8M | ﹤0.01% |
2,119,646
-20,982
| -1% | -$126K |
|
1145
ProShares Ultra S&P500
SSO
$7.39B
| $12.8M | ﹤0.01% |
137,827
-56,234
| -29% | -$5.2M |
|
1146
The Ensign Group
ENSG
$9.69B
| $12.7M | ﹤0.01% |
95,726
-38,126
| -28% | -$5.07M |
|
1147
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$7.63B
| $12.7M | ﹤0.01% |
437,607
+310,933
| +245% | +$9.03M |
|
1148
TC Energy
TRP
$54.4B
| $12.7M | ﹤0.01% |
273,027
-126,293
| -32% | -$5.88M |
|
1149
Rocket Lab Corporation Common Stock
RKLB
$25.7B
| $12.6M | ﹤0.01% |
496,305
-2,654,770
| -84% | -$67.6M |
|
1150
Valmont Industries
VMI
$7.37B
| $12.6M | ﹤0.01% |
41,218
-50,923
| -55% | -$15.6M |
|